ChromoCare, a Columbus, OH-based genetics-testing company, received an investment from Bryan Lindsey*.
The amount of the deal was not disclosed.
Founded in 2013 by Jeff Garshon, president, and led by Chairman & CEO Hugh Cathey, Garshon, and COO Jodie Fortine, ChromoCare has developed a proprietary test and multifactorial algorithm related to medication compatibility within 24 genes in the human body. Its product is
Its G•A•P Test™ is a genetic medication-compatibility test that brings added insight, reduces adverse events and the need for repeat office visits or ER visits, due to incompatible drug or dosage issues. It is able to identify when a patient will not benefit from 350+ medications, including opiates, due to their genetic inability to metabolize the drug.
The company0s next product, ChromoALERT™, is a platform that enables the patient and physician insight into the individual’s genetic based susceptibility to addiction. These two factors can now be utilized to inform treatment decisions and provide safer pain management treatment.
* Bryan Lindsey is an investor, business owner, seasoned hospitality leader and philanthropist. One of his most notable partnerships is with Tuff-N-Uff MMA, the largest amateur mixed martial arts organization in the world and developer of the future stars of MMA, such as superstar Ronda Rousey. The senior level executive had spent nearly 20 years with Station Casinos, now named Red Rock Resorts Inc. (RRR) and recently left his position post the RRR initial public offering, which resulted in the company raising $531.4 million. He held numerous positions, both at the property level at resorts such as Green Valley Ranch in Henderson and Red Rock Resort in Summerlin, as well as at the Corporate Headquarters.
FinSMEs
03/09/2018